학술논문

Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia
Document Type
article
Source
BMC Urology. 21(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Oncology and Carcinogenesis
Cancer
Clinical Research
Aging
Prevention
Urologic Diseases
Prostate Cancer
Obesity
Nutrition
Metabolic and endocrine
Age Factors
Body Size
Humans
Male
Middle Aged
Nocturia
Prostatic Hyperplasia
Benign Prostatic Hyperplasia
Body size
Prostate volume
PLCO
Urology & Nephrology
Clinical sciences
Language
Abstract
BackgroundExisting evidence suggests that there is an association between body size and prevalent Benign Prostatic Hyperplasia (BPH)-related outcomes and nocturia. However, there is limited evidence on the association between body size throughout the life-course and incident BPH-related outcomes.MethodsOur study population consisted of men without histories of prostate cancer, BPH-related outcomes, or nocturia in the intervention arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) (n = 4710). Associations for body size in early- (age 20), mid- (age 50) and late-life (age ≥ 55, mean age 60.7 years) and weight change with incident BPH-related outcomes (including self-reported nocturia and physician diagnosis of BPH, digital rectal examination-estimated prostate volume ≥ 30 cc, and prostate-specific antigen [PSA] concentration > 1.4 ng/mL) were examined using Poisson regression with robust variance estimation.ResultsMen who were obese in late-life were 25% more likely to report nocturia (Relative Risk (RR): 1.25, 95% Confidence Interval (CI): 1.11-1.40; p-trendfor continuous BMI